Dilution of equity value resulting from the exercise of stock acquisition rights
First written in FY2018. 7 of 25 entries say "Materialised", first in FY2019-Q3. Latest entry: FY2026.
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
52 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「As of the filing date, the potential shares represented by the stock acquisition rights totaled 103,880 shares, equivalent to 2.19% of the total number of issued common shares.」
The potential share ratio declined from 7.98% in the previous fiscal year to 2.19%, reducing the potential for future dilution through stock acquisition rights numerically. - FY2026-H1MitigatedAnnual report
「Stock options Number of stock acquisition rights 7 types Number of common shares 110,260 shares」
The number of potential shares declined from 134,540 shares in the previous interim consolidated accounting period to 110,260 shares, reducing the potential for future dilution numerically. - FY2025Potential share ratio down, number of shares upAnnual report
「As of the filing date, the potential shares represented by the stock acquisition rights totaled 141,060 shares, equivalent to 2.97% of the total number of issued common shares.」
The potential share ratio declined from 7.98% in the previous fiscal year to 2.97%. Meanwhile, the number of potential shares increased from the previously disclosed 134,540 shares to 141,060 shares. - FY2025-H1MitigatedAnnual report
「Stock options Number of stock acquisition rights 5,557 units Number of common shares 358,800 shares Stock options Number of stock acquisition rights 2,732 units Number of common shares 134,540 shares」
Among potential shares that underwent a material change from the end of the previous consolidated fiscal year, the number of stock acquisition rights declined from 5,557 units to 2,732 units, and the number of underlying common shares declined from 358,800 shares to 134,540 shares. - FY2024-Q2RaisedAnnual report
「12th Series of Stock Acquisition Rights Resolution date 17 August 2023 Category and number of grantees (people) Company employees 65 Number of stock acquisition rights (units) (Note 1) 325 Class of shares underlying stock acquisition rights (Note 1) Common shares Number of shares underlying stock acquisition rights (shares) (Note 1) 32,500 (Note 2) Exercise period for stock acquisition rights (Note 1) From 17 August 2025 to 19 July 2032」
The company issued 12th-series stock acquisition rights covering 32,500 shares to 65 employees, adding to the potential for future dilution. Meanwhile, the 1,000 remaining 9th-series stock acquisition rights were acquired and cancelled as of 31 August 2023. - FY2024-Q1RaisedAnnual report
「12th Series of Stock Acquisition Rights Resolution date 19 July 2023 Category and number of grantees (people) Company employees 72 Number of stock acquisition rights (units) (Note 1) 360 Number of shares underlying stock acquisition rights (shares) (Note 1) 36,000 (Note 2) Exercise period for stock acquisition rights (Note 1) From 17 August 2025 to 19 July 2033」
As an event after the filing, the company disclosed a resolution to issue 12th-series stock acquisition rights covering 36,000 shares to 72 employees, adding to the potential for future dilution. - FY2023RaisedAnnual report
「As of the filing date, the potential shares represented by the stock acquisition rights totaled 378,880 shares, equivalent to 7.98% of the total number of issued common shares.」
The potential share ratio rose from 3.78% in the previous fiscal year to 7.98%, increasing the potential for future dilution of share value numerically. - FY2023-Q2RaisedAnnual report
「10th Series of Stock Acquisition Rights Resolution date 20 July 2022 Category and number of grantees (people) Company employees 74 Number of stock acquisition rights (units) (Note 1) 370 Number of shares underlying stock acquisition rights (shares) (Note 1) 37,000 (Note 2) Exercise period for stock acquisition rights (Note 1) From 15 August 2024 to 20 July 2032」
Stock acquisition rights covering 37,000 shares were issued to 74 employees, adding to the potential for future dilution. - FY2023-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
It is stated that there has been no new occurrence or material change regarding the risk of dilution of share value through the exercise of stock acquisition rights. - FY2022MitigatedAnnual report
「As of the filing date, the potential shares represented by the stock acquisition rights totaled 179,520 shares, equivalent to 3.78% of the total number of issued common shares.」
The potential share ratio declined from 6.70% in the previous fiscal year to 3.78%. Although the potential for dilution remains, it has declined numerically. - FY2022-Q3MaterialisedAnnual report
「1 October 2021–31 December 2021 (Note) Increase due to the exercise of stock acquisition rights. 13,300」
During the third quarter, 13,300 shares increased through the exercise of stock acquisition rights, and the actual issuance of shares serving as a source of dilution has occurred. - FY2022-Q2RestatedAnnual report
「During the six-month period ended [the current second quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
It is stated that there has been no new occurrence or material change regarding the risk of dilution of share value through the exercise of stock acquisition rights. - FY2022-Q1MaterialisedAnnual report
「1 April 2021–30 June 2021 (Note) Increase due to the exercise of stock acquisition rights. 28,420」
During the first quarter, 28,420 shares increased through the exercise of stock acquisition rights, and the continued issuance of shares serving as a source of dilution is confirmed. - FY2021MitigatedAnnual report
「As of the filing date, the potential shares represented by the stock acquisition rights totaled 315,580 shares, equivalent to 6.70% of the total number of issued common shares.」
The potential share ratio declined from 8.91% in the previous fiscal year to 6.70%. While all of the 8th-series stock acquisition rights were exercised and 400,000 shares were delivered, 200,000 shares under the 9th-series stock acquisition rights remain outstanding, so the potential for dilution continues. - FY2021-Q3MaterialisedAnnual report
「Number of shares delivered upon exercise during the quarter 318,000 Funds raised through exercises during the quarter (¥ thousand) 541,382」
During the third quarter, 318,000 shares were delivered through the exercise of the 8th series of stock acquisition rights, raising ¥541,382 thousand. The issuance of shares through the exercise of stock acquisition rights progressed substantially, and dilution has actually occurred. - FY2021-Q2RaisedAnnual report
「Class, details and number of shares underlying stock acquisition rights (shares)* Common shares 200,000 Class, details and number of shares underlying stock acquisition rights (shares)* Common shares 100,000」
The 8th and 9th series of stock acquisition rights were issued, adding potential dilution on a share-count basis. With respect to the 8th series, rights equivalent to 41,000 shares were exercised during the quarter, and the actual issuance of shares has also been confirmed. - FY2021-Q1MaterialisedAnnual report
「1 April 2020–30 June 2020 (Note) Increase due to the exercise of stock acquisition rights. 4,000」
During the first quarter, 4,000 shares increased through the exercise of stock acquisition rights, and the continued issuance of shares serving as a source of dilution is confirmed. - FY2020RaisedAnnual report
「As of the filing date, the potential shares represented by stock acquisition rights totaled 188,340 shares, equivalent to 8.91% of the total number of issued common shares.」
The potential share ratio rose from 7.46% in the previous fiscal year to 8.91%. While shares continued to be issued through the exercise of stock acquisition rights, the potential for future dilution increased numerically. - FY2020-Q2MaterialisedAnnual report
「1 July 2019–30 September 2019 3,130 2,109,820 4,069 466,729 4,069 451,729 (Note) Increase due to the exercise of stock acquisition rights.」
During the second quarter, 3,130 shares increased through the exercise of stock acquisition rights, and capital stock and capital surplus each increased by ¥4,069 thousand. The continued issuance of shares serving as a source of dilution is confirmed. - FY2020-Q1MaterialisedAnnual report
「1 April 2019–30 June 2019 7,600 2,106,690 9,120 462,660 9,120 447,660 (Note) Increase due to the exercise of stock acquisition rights.」
During the first quarter, 7,600 shares increased through the exercise of stock acquisition rights, and capital stock and capital surplus each increased by ¥9,120 thousand. The issuance of shares serving as a source of dilution is confirmed. - FY2019MitigatedAnnual report
「As of the filing date, the potential shares represented by stock acquisition rights totaled 156,980 shares, equivalent to 7.46% of the total number of issued common shares.」
The potential share ratio declined from 10.15% in the previous disclosure to 7.46%, while 24,850 shares were issued through the exercise of stock acquisition rights during the fiscal year, leaving a source of dilution. - FY2019-Q3MaterialisedAnnual report
「17,150」
17,150 shares increased through the exercise of stock acquisition rights between 1 October 2018 and 31 December 2018. The issuance of shares through the exercise of stock acquisition rights is confirmed, but no specific impact on share value is described. - FY2019-Q2RestatedAnnual report
「During the six-month period ended [the current second quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
It is stated that there has been no new occurrence or material change regarding the risk of dilution of share value through the exercise of stock acquisition rights. - FY2019-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The risk of dilution of share value through the exercise of stock acquisition rights is collectively stated as having had no additional occurrence or material change. - FY2018First statedAnnual report
「As of the filing date, the potential shares represented by stock acquisition rights totaled 206,660 shares, equivalent to 10.15% of the total number of issued common shares.」
The company discloses that the exercise of stock acquisition rights may affect the value of the shares and supply and demand in share trading after listing.